We found that major determinants of variation in the number of CACs were the thrombolytic treatment, previously diagnosed hypertension, the number of risk factors, the variation in VEGF expression, and LOECs culture appearance, whereas independent predictors of CFU-ECs were hemoglobin and the relative reduction in NIHSS criteria. This evidence concerns the gene VEGFA and Hypertension.